Home/Filings/4/0001179110-19-000459
4//SEC Filing

Chen Hongming 4

Accession 0001179110-19-000459

CIK 0001479419other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:02 PM ET

Size

10.1 KB

Accession

0001179110-19-000459

Insider Transaction Report

Form 4
Period: 2019-01-02
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-02+150,000150,000 total
    Exercise: $5.19Exp: 2029-01-01Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 2, 2019 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.

Issuer

Kala Pharmaceuticals, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001710697

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:02 PM ET
Size
10.1 KB